Margaret (Peg) McCormick
Margaret McCormick is a distinguished pharmaceutical and biotech executive with a passion for improving the patient experience in the face of chronic illnesses.
She is sought after by companies and patient organizations for her expertise in understanding patient perspectives on diagnosis and treatment decisions, particularly in areas like cell therapies, including CAR-T, and clinical trial accrual.
Margaret excels in guiding therapeutic areas and product teams in developing patient engagement strategies, fostering positive relationships with patient advocacy organizations and societies, and enhancing clinical trial enrollment in hematologic malignancies.
She is a renowned national speaker on patient engagement, clinical trials, and access to care, with a focus on mindfulness-based approaches to patient and professional engagement.
Margaret holds an MBA from the University of Pennsylvania - The Wharton School, a Master's Degree in Transpersonal Counseling Psychology from Naropa University, and a BSN in Nursing from the University of Minnesota.
Her professional journey includes roles such as Consultant Patient Affairs at Autolus Ltd., Founder of McCormick Counseling, Senior Director positions at The Leukemia & Lymphoma Society and Genzyme, leadership roles at Novartis Pharmaceutical, US Oncology, and Roche Pharmaceuticals, among others.
She has a diverse background that spans marketing, clinical affairs, alliance development, and patient relations across renowned pharmaceutical companies and healthcare institutions.
